Electromed Inc. reported adjusted fourth-quarter earnings that exceeded analyst forecasts, though revenue fell short of projections as shares slipped in after-hours trading.
The NYSE American-listed company posted adjusted earnings per share of $0.39 for the quarter ended June 30, up from $0.25 a year earlier and ahead of the $0.31 consensus estimate. Net income rose 54.3% to $3.4 million, while revenue increased 11.6% year-over-year to $19.4 million, slightly below the $19.5 million estimate.
Direct homecare revenue, the company’s primary segment, grew 15.2% to $17.7 million. Operating income climbed 25.8% to $3.8 million, representing 19.7% of net revenues, and gross margin expanded to 78.7% from 78.3% in the prior-year period.
For the full fiscal year, Electromed posted a record $73.8 million in revenue, a 15.3% increase from $64.0 million in fiscal 2025. Net income rose to $11.3 million, or $1.30 per diluted share, compared with $7.5 million, or $0.85 per share, a year earlier. Operating income grew 43.7% to $13.9 million, accounting for 18.8% of annual revenue. Direct homecare revenue for the year increased 16.3% to $66.6 million.
The company held $20.5 million in cash with no debt as of June 30. Electromed’s stock closed at $39.34 on August 25, down $0.95, or 2.36%, following the earnings release. In after-hours trading, shares were down an additional 2.01% to $38.55.
Chief Executive Jim Cunniff highlighted the company’s 15th consecutive quarter of year-over-year revenue and profit growth, calling fiscal 2026 an exceptional year for Electromed.
